Hot News

US FDA approves new "female Viagra" @ 2019-06-22T12: Back Hot News
Keyword:FDA approves female Viagra
Concept:
The US Food and Drug Administration on Friday approved Palatin Technologies Inc. and Amag Pharmaceuticals Inc."s drug to restore sexual desire in ...
Women in the US will soon have another drug option designed to boost low sex drive: a shot they can give themselves that raises sexual interest for several ...
The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals" drug to restore sexual desire in premenopausal women, the latest ...
Pharmaceutical known chemically as bremelanotide is aimed at women with low sexual desire disorder or HSDD. Staff and agencies. Fri 21 Jun 2019 22.15 ...
The Food and Drug Administration has approved another drug to increase female libido, becoming the second one to hit the market. According to The New York ...
The Food and Drug Administration (FDA) approved a drug Friday to restore sexual desire for premenopausal women who suffer from hypoactive sexual desire ...
Bremelanotide becomes the second FDA-approved drug for hypoactive sexual desire disorder in premenopausal women. It is self-injected at least 45 minutes ...
U.S. health regulators approved a second drug to treat low sexual desire in women, adding another option to an area of medicine that"s become better known for ...
The Food and Drug Administration on Friday approved Vyleesi, an injection designed to heighten women"s sex drive.
Women"s libidos are about to get a shot in the arm thanks to a drug the Food and Drug Administration approved Friday.

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.